|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.41 CNY | -2.08% |
|
+5.90% | -25.95% |
Shanghai Rendu Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 304.22 million compared to CNY 292.31 million a year ago. Net income was CNY 19.08 million compared to CNY 64.62 million a year ago.
Basic earnings per share from continuing operations was CNY 0.51 compared to CNY 2.15 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -25.95% | 185M | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.70% | 40.7B | |
| +3.43% | 26.53B | |
| +13.67% | 25.02B | |
| -0.32% | 24.96B |
SHANGHAI RENDU BIOTECHNOLOGY CO., LTD. 
